Evidence map›Paper›PMID 40078378›Full record

ArticleAlzheimer's & dementia (Amsterdam, Netherlands)

The role of cerebrovascular reactivity on brain activation during a working memory task in type 2 diabetes.

Yarden Oliel, Ramit Ravona-Springer, Maayan Harel, Joseph Azuri, Chen Botvin Moshe, David Tanne, Salo Haratz, Barbara B Bendlin, Michal Schnaider Beeri, Abigail Livny

Abstract read
In one paragraph

Article in Alzheimer's & dementia (Amsterdam, Netherlands). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yarden OlielDivision of Diagnostic Imaging Sheba Medical Center Ramat Gan Israel.
Ramit Ravona-SpringerThe Joseph Sagol Neuroscience Center Sheba Medical Center Ramat Gan Israel.
Maayan HarelDivision of Diagnostic Imaging Sheba Medical Center Ramat Gan Israel.
Joseph AzuriFaculty of Medical & Health Sciences Tel-Aviv University Tel Aviv-Yafo Israel.
Chen Botvin MosheThe Joseph Sagol Neuroscience Center Sheba Medical Center Ramat Gan Israel.
David TanneStroke and Cognition Institute Rambam Health Care Campus Haifa Israel.
Salo HaratzSamson Assuta Ashdod University Hospital Ashdod Israel.
Barbara B BendlinWisconsin Alzheimer's Disease Research Center School of Medicine and Public Health University of Wisconsin-Madison Madison Wisconsin USA.
Michal Schnaider BeeriKrieger Klein Alzheimer's Research Center Brain Health Institute Rutgers University Piscataway New Jersey USA.
Abigail LivnyDivision of Diagnostic Imaging Sheba Medical Center Ramat Gan Israel.ORCID https://orcid.org/0000-0003-2216-7357

Funding

Research Education ComponentP30AG066514 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Margaret Sewell · 2020 to 2026
$31.0M
Systemic and dietary advanced glycation end products in type 2 diabetes-related cognitive decline and incident dementia: effects on Alzheimer's pathology and cerebrovascular diseaseR01AG061093 · NIA · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI SCHNAIDER BEERI, MICHAL · 2019 to 2024
$4.3M
Peripheral and brain levels of advanced glycation end products AGEs and incident Alzheimers disease and neuropathologyR01AG053446 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SCHNAIDER BEERI, MICHAL, URIBARRI, JAIME · 2016 to 2021
$3.8M
Hyperbaric oxygen therapy for cognition in diabetic elderly at high dementia riskR01AG051545 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SANO, MARY, SCHNAIDER BEERI, MICHAL · 2016 to 2021
$3.7M
Cognitive and brain imaging correlates of apathy- components in asymptomatic middle aged individuals at high ADRD- riskR21AG080827 · NIA · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI RAVONA, RAMIT, SCHNAIDER BEERI, MICHAL · 2023 to 2024
$365k
NIA NIH HHS P30 AG066514NIA NIH HHS R01 AG051545NIA NIH HHS R01 AG053446NIA NIH HHS R01 AG061093NIA NIH HHS R21 AG080827
6 · The paper itself

Abstract

introductionImpaired cerebrovascular reactivity (CVR) is common in type 2 diabetes (T2D) patients and is a risk factor for dementia. However, most prior functional magnetic resonance imaging (fMRI) studies in T2D disregarded the impact of impaired CVR on brain activation patterns. This study investigated the relationship between CVR and brain activation during an fMRI task in T2D patients.

methodsSeventy-four T2D patients underwent a working-memory (WM) fMRI task. CVR was measured by the breath-holding index test using transcranial Doppler (TCD). Regression analyses examined associations between CVR and brain activation and between glycated hemoglobin (HbA1c) and activation with/without adjusting for CVR.

resultsAn association between CVR and brain activation was found in the left middle and inferior frontal gyri. Adjusting for CVR led to a different pattern of HbA1c-related activation. DISCUSSION: The findings highlight methodological implications, emphasizing the importance of accounting for impaired CVR when analyzing and interpreting fMRI data in T2D patients. Highlights: The study found that cerebrovascular reactivity impacts brain activation patterns during a working memory task in type 2 diabetes patients.Accounting for cerebrovascular reactivity altered the brain regions showing activation related to working memory and glycemic control.The findings highlight the importance of considering vascular factors when interpreting fMRI data in populations with vascular dysfunction.

Indexed as

Alzheimer's diseasebraincerebrovascular reactivityfMRItype‐2 diabetesworking memory

Identifiers

PMID40078378
PMCPMC11899760

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.